Vertex Pharmaceuticals (VRTX)
(Delayed Data from NSDQ)
$397.70 USD
-3.06 (-0.76%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $397.89 +0.19 (0.05%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth B Momentum C VGM
Detailed Estimates
EPS Estimates
Earnings Date | *AMC5/6/24 |
---|---|
Current Quarter | 4.10 |
EPS Last Quarter | 4.20 |
Last EPS Surprise | 2.44% |
ABR | 1.87 |
Earnings ESP
|
-1.17% |
---|---|
Current Year | 16.76 |
Next Year | 18.00 |
EPS (TTM) | 15.22 |
P/E (F1) | 23.91 |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 2.56B | 2.64B | 10.69B | 11.69B |
# of Estimates | 11 | 11 | 12 | 12 |
High Estimate | 2.61B | 2.70B | 10.77B | 13.12B |
Low Estimate | 2.45B | 2.56B | 10.61B | 11.08B |
Year ago Sales | 2.37B | 2.49B | 9.87B | 10.69B |
Year over Year Growth Est. | 7.75% | 5.76% | 8.29% | 9.34% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 4.10 | 4.08 | 16.76 | 18.00 |
# of Estimates | 12 | 10 | 14 | 13 |
Most Recent Consensus | 4.16 | 4.24 | 17.03 | 17.03 |
High Estimate | 4.44 | 4.29 | 18.00 | 20.54 |
Low Estimate | 3.75 | 3.77 | 15.15 | 14.58 |
Year ago EPS | 3.05 | 3.89 | 15.23 | 16.76 |
Year over Year Growth Est. | 34.43% | 4.88% | 10.05% | 7.39% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 3 | 1 | 2 | 0 |
Up Last 60 Days | 4 | 1 | 3 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 1 |
Down Last 30 Days | 1 | 0 | 1 | 5 |
Down Last 60 Days | 1 | 1 | 1 | 4 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 4.10 | 4.08 | 16.76 | 18.00 |
7 Days Ago | 4.10 | 4.08 | 16.76 | 18.00 |
30 Days Ago | 4.07 | 4.06 | 16.79 | 18.19 |
60 Days Ago | 4.06 | 4.07 | 16.79 | 18.19 |
90 Days Ago | 4.27 | 4.31 | 16.55 | 17.72 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 4.05 | 4.00 | 16.54 | 17.25 |
Zacks Consensus Estimate | 4.10 | 4.08 | 16.76 | 18.00 |
Earnings ESP | -1.17% | -1.84% | -1.34% | -4.14% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 4.20 | 4.08 | 3.89 | 3.05 | NA |
Estimate | 4.10 | 3.92 | 3.85 | 2.95 | NA |
Difference | 0.10 | 0.16 | 0.04 | 0.10 | 0.10 |
Surprise | 2.44% | 4.08% | 1.04% | 3.39% | 2.74% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more